COMMITMENTS AND CONTINGENCIES (Details) $ in Thousands |
3 Months Ended | 9 Months Ended | 12 Months Ended | |||
---|---|---|---|---|---|---|
Jan. 19, 2024
USD ($)
|
Sep. 30, 2024
subsidiary
|
Sep. 30, 2023
claim
|
Sep. 30, 2024
subsidiary
|
Sep. 30, 2023
claim
|
Dec. 31, 2023 |
|
Concentration Risk [Line Items] | ||||||
Litigation settlement, amount awarded to other party | $ | $ 48,000 | |||||
Facilities under Medicare probe reviews | subsidiary | 18 | 18 | ||||
Number of claims from each SNF reviewed by CMS in compliance audit | claim | 5 | 5 | ||||
Accounts Receivable | Customer Concentration Risk | Total Medicaid and Medicare | ||||||
Concentration Risk [Line Items] | ||||||
Concentration percentage | 53.50% | 53.40% | ||||
Revenue | Customer Concentration Risk | Service revenue | ||||||
Concentration Risk [Line Items] | ||||||
Concentration percentage | 100.00% | 100.00% | 100.00% | 100.00% | ||
Revenue | Customer Concentration Risk | Total Medicaid and Medicare | Service revenue | ||||||
Concentration Risk [Line Items] | ||||||
Concentration percentage | 70.20% | 72.10% | 71.00% | 72.80% |